Skip to main content
    B

    Bicycle Therapeutics Ltd (BCYC)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $3.18
    -0.19 (-5.64%)

    Market Cap: $236.22M

    Last updated: Nov 17, 2026 at 11:04 AM ET

    Bicycle Therapeutics Ltd (BCYC) Earnings: Report Dates and Results

    Updated Oct 29, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Bicycle Therapeutics (BCYC) is expected to report earnings on Mar 15, 2027. In the quarter ended Sep 30, 2026, Bicycle Therapeutics reported EPS of -$0.15, above the -$0.30 estimate. It beat the EPS estimate in 4 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    43%(13/30)
    Avg Surprise
    -5.61%
    Streak
    1 Q

    Upcoming Estimates

    Reports Mar 15, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$0.44
    Range-$0.64 - $0.33
    12 analysts
    Revenue Consensus
    $1.86M
    Range$539.00K - $6.30M
    11 analysts
    Reports Apr 28, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus-$0.61
    Range-$0.65 - -$0.55
    3 analysts
    EPS Revisions
    1
    0
    30d
    EPS Estimate DriftChange to current
    90d ago-$0.59-3.7%
    60d ago-$0.59-3.7%
    30d ago-$0.59-3.7%
    7d ago-$0.59-3.7%
    Current-$0.61
    Revenue Consensus
    $1.07M
    RangeN/A
    4 analysts

    Next Report

    BCYC has an expected report date of Mar 15, 2027.

    Earnings History

    Of the 30 quarters below that had an estimate, BCYC beat 13 and missed 17. Revenue for the quarter ended Sep 30, 2026 was $34.06M, up 190.4% from $11.73M a year earlier.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026-$0.15-$0.30-$0.65 - -$0.04+50.00%BeatN/A82 up, 0 downOct 29, 2026$34.06M
    Jun 30, 2026-$0.72-$0.37-$0.75 - -$0.37-94.59%MissN/A71 up, 1 downJul 30, 2026$629000
    Mar 31, 2026-$0.87-$0.67-$0.80 - -$0.44-29.85%MissN/A95 up, 0 downApr 30, 2026$887000
    Dec 31, 2025-$0.29-$0.94-$1.18 - -$0.79+69.06%BeatN/A11N/AMar 17, 2026$47.95M
    Sep 30, 2025-$0.85-$1.07-$1.27 - -$0.74+20.56%BeatN/A81 up, 5 downOct 30, 2025$11.73M
    Jun 30, 2025-$1.14-$0.93-$1.07 - -$0.69-22.58%MissN/A70 up, 1 downAug 8, 2025$2.92M
    Mar 31, 2025-$0.88-$0.85-$0.91 - -$0.69-3.53%MissN/A40 up, 1 downMay 1, 2025$9.98M
    Dec 31, 2024-$0.81-$0.85-$1.20 - -$0.68+4.59%BeatN/A101 up, 0 downFeb 25, 2025$3.71M
    Sep 30, 2024-$0.72-$0.78-$1.05 - -$0.54+7.69%BeatN/A130 up, 0 downOct 31, 2024$2.68M
    Jun 30, 2024-$0.77-$1.11-$1.35 - -$0.89+30.63%BeatN/A122 up, 0 downAug 6, 2024$9.36M
    Mar 31, 2024-$0.62-$1.21-$1.40 - -$1.03+48.76%BeatN/A110 up, 1 downMay 2, 2024$19.53M
    Dec 31, 2023-$1.16-$1.23-$1.65 - -$0.67+5.69%BeatN/A131 up, 0 downFeb 20, 2024$5.33M
    Sep 30, 2023-$1.26-$1.06-$1.85 - -$0.23-18.87%MissN/A140 up, 0 downNov 2, 2023$5.35M
    Jun 30, 2023-$1.41-$1.07-$1.65 - -$1.05-31.78%MissN/A120 up, 0 downAug 3, 2023$11.40M
    Mar 31, 2023-$1.30-$0.96N/A-35.42%MissN/A131 up, 0 downMay 4, 2023$4.90M
    Dec 31, 2022-$1.01-$1.06-$1.20 - -$0.94+4.72%BeatN/A150 up, 0 downFeb 28, 2023$3.19M
    Sep 30, 2022-$0.96-$0.91-$1.15 - -$0.44-5.49%MissN/A150 up, 0 downNov 3, 2022$3.04M
    Jun 30, 2022-$0.90-$0.81-$1.15 - -$0.66-11.11%MissN/A140 up, 0 downAug 4, 2022$4.38M
    Mar 31, 2022-$0.93-$0.72-$0.84 - -$0.36-29.17%MissN/A120 up, 0 downMay 5, 2022$3.86M
    Dec 31, 2021-$0.63-$0.61-$1.23 - -$0.13-3.28%MissN/A131 up, 0 downMar 1, 2022$3.77M
    Sep 30, 2021-$0.59-$0.63-$0.76 - -$0.26+6.35%BeatN/A91 up, 0 downNov 4, 2021$4.33M
    Jun 30, 2021-$0.74-$0.67-$1.08 - -$0.58-10.45%MissN/A8N/AAug 5, 2021$1.78M
    Mar 31, 2021-$0.73-$0.71-$0.95 - -$0.53-2.82%MissN/A6N/AMay 6, 2021$1.81M
    Dec 31, 2020-$0.83-$0.47-$0.77 - -$0.20-76.60%MissN/A8N/AMar 11, 2021$3.85M
    Sep 30, 2020-$0.52-$0.53-$0.72 - -$0.12+1.89%BeatN/A8N/ANov 5, 2020$3.84M
    Jun 30, 2020-$0.67-$0.46-$0.71 - -$0.27-45.65%MissN/A7N/AAug 5, 2020$1.57M
    Mar 31, 2020-$0.63-$0.38-$0.55 - $1.09-65.79%MissN/A6N/AMay 7, 2020$1.13M
    Dec 31, 2019-$0.25-$0.52-$0.58 - -$0.47+51.92%BeatN/A5N/AMar 10, 2020$5.28M
    Sep 30, 2019-$0.53-$0.69-$0.88 - -$0.33+23.19%BeatN/A4N/ANov 7, 2019$614000
    Jun 30, 2019-$0.66-$0.62-$0.62 - -$0.29-6.45%MissN/A4N/AAug 8, 2019$1.52M
    Mar 31, 2019-$0.45N/AN/AN/AN/AN/AN/AN/AMay 23, 2019$6.38M
    Sep 30, 2018-$0.78N/AN/AN/AN/AN/AN/AN/ADec 21, 2018$1.61M
    Jun 30, 2018-$0.37N/AN/AN/AN/AN/AN/AN/AJun 30, 2018$1.66M
    Mar 31, 2018-$0.19N/AN/AN/AN/AN/AN/AN/AMar 31, 2018$2.81M
    Dec 31, 2017-$0.38N/AN/AN/AN/AN/AN/AN/ADec 31, 2017$655000
    Last 35 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was -$3.16, after -$2.92 the year before. It was -$0.76 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025-$3.16N/A
    Dec 31, 2024-$2.92N/A
    Dec 31, 2023-$5.13N/A
    Dec 31, 2022-$3.80N/A
    Dec 31, 2021-$2.69N/A
    Dec 31, 2020-$2.65N/A
    Dec 31, 2019-$2.67N/A
    Dec 31, 2018-$1.64N/A
    Dec 31, 2017-$1.22N/A
    Dec 31, 2016-$0.76N/A

    Frequently Asked Questions About BCYC

    When is Bicycle Therapeutics's next earnings date?

    Bicycle Therapeutics's next earnings report is expected for Mar 15, 2027.

    Did BCYC beat earnings estimates last quarter?

    Yes. Bicycle Therapeutics reported EPS of -$0.15 for the quarter ended Sep 30, 2026, above the -$0.30 estimate, a 50.00% surprise.

    What EPS do analysts expect from BCYC next quarter?

    The consensus EPS estimate for Bicycle Therapeutics for the quarter ending Dec 31, 2026 is -$0.44 from 12 analysts, with estimates from -$0.64 to $0.33.

    How often does BCYC beat earnings estimates?

    Bicycle Therapeutics beat the EPS estimate in 4 of the last 8 quarters, with an average surprise of -0.79%.